Sarah Khan

87PUBLICATIONS
332CO-AUTHORS
Metabolic medicineEpidemiological modellingMedical biotechnology diagnostics (incl. biosensors)Medical virologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (87)

|Aug 25, 2026
Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

|Aug 10, 2026
Short-Term Risk Stratification in Alcohol-Associated Hepatitis: Small HDL Particles and Inflammation Vulnerability Index Values Improve Model for End-Stage Liver Disease.

|Jul 22, 2026
AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models.

|Jul 20, 2026
A precision-constrained framework for evaluating noninvasive biomarkers in MASLD and beyond.

|Jul 17, 2026
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

|Jun 23, 2026
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Pageof 15

Frequent Collaborators

20 joint publications

Rohit Loomba

11 joint publications

Quentin M Anstee

8 joint publications

Brent Neuschwander-Tetri

7 joint publications

Vlad Ratziu